Clinical trial
RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment
NCT00258921 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00258921 |
|---|---|
| Title | RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment |
| Official title | An International Registry in Essential Hypertension |
| Acronym | RIAT |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hypertension |
| Enrollment | 31,870 |
| Start date | Mar 1, 2004 |
| Completion | Jul 1, 2006 |
| First posted | Nov 28, 2005 |
| Last update posted | Nov 22, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: